US2017202170A1PendingUtilityA1

Breeding, production, processing and use of specialty cannabis

66
Assignee: BIOTECH INST LLCPriority: Mar 15, 2013Filed: Jan 6, 2017Published: Jul 20, 2017
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
A01H 4/008A61K 36/3482A61K 31/352A61K 31/05A61K 31/047A61K 31/045A61K 31/015A61P 25/22A01H 5/02A23L 33/105A01H 1/02A61K 36/185A23V 2002/00A01H 1/04A01H 5/12A01H 6/28A01G 22/67B01D 11/0203B01D 11/0288
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.

Claims

exact text as granted — not AI-modified
1 . A cannabis plant, or an asexual clone of said cannabis plant, or a plant part, tissue, or cell thereof, which produces a female inflorescence, said inflorescence comprising:
 a) B D /B D  genotype;   b) a terpene profile in which myrcene is not the dominant terpene; and   c) a terpene oil content greater than about 1.0% by weight;   wherein the terpene oil content is the additive content of the terpenes in the inflorescence's terpene profile; wherein the terpene profile consists of terpinolene, alpha phellandrene, beta ocimene, carene, limonene, gamma terpinene, alpha pinene, alpha terpinene, beta pinene, fenchol, camphene, alpha terpineol, alpha humulene, beta caryophyllene, linalool, caryophyllene oxide, and myrcene; and wherein the terpene contents are measured by gas chromatography-flame ionization detection (GC-FID) and are calculated based on dry weight of the inflorescence; wherein cellular cultures representative of said plants are deposited under Bigelow NCMA Nos. “PP03”, “PP11”, “YEL03_P26_S1_51”, “XC537_B4C503_20”, “O3N505.03N509.65”, and “P08S174_P38S108_16”.   
     
     
         2 . The Cannabis plant, or an asexual clone of said Cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 , wherein the female inflorescence comprises a cannabidiol (CBD) content that is at least 3.0%, wherein the CBD content comprises the content of acidic and decarboxylated CBD as measured by high performance liquid chromatography (HPLC) and calculated based on dry weight of the inflorescence. 
     
     
         3 . The Cannabis plant, or an asexual clone of said Cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 , wherein the female inflorescence comprises a cannabidiol (CBD) content that is at least 6.0%, wherein the CBD content comprises the content of acidic and decarboxylated CBD as measured by high performance liquid chromatography (HPLC) and calculated based on dry weight of the inflorescence. 
     
     
         4 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein the female inflorescence comprises at least 1.4% terpene oil content. 
     
     
         5 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein the female inflorescence comprises between 1.0% and 2.0% terpene oil content. 
     
     
         6 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein terpinolene is the most abundant terpene in said terpene profile. 
     
     
         7 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein limonene is the most abundant terpene in said terpene profile. 
     
     
         8 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein alpha pinene is the most abundant terpene in said terpene profile. 
     
     
         9 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein alpha humulene is the most abundant terpene in said terpene profile. 
     
     
         10 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein beta caryophyllene is the most abundant terpene in said terpene profile. 
     
     
         11 . The cannabis plant, or an asexual clone of said cannabis plant, or plant part, tissue, or cell thereof of  claim 1 , wherein linalool is the most abundant terpene in said terpene profile. 
     
     
         12 . A method of breeding for a cannabis plant, wherein said cannabis plant produces an inflorescence comprising a B D /B D  genotype, a terpene oil content greater than 1.0%, and a terpene profile in which myrcene is not the dominant terpene, said method comprising:
 (i) making a cross between a first cannabis plant of  claim 1 , or an asexual clone of said first cannabis plant and a second cannabis plant to produce an F1 seed:   (ii) harvesting the resulting seed;   (iii) growing one or more of said harvested seed; and   (iv) selecting a cannabis plant with a desired phenotype;   
       wherein the resulting selected cannabis plant produces an inflorescence comprising a B D /B D  genotype, a terpene oil content greater than 1.0%, and a terpene profile in which myrcene is not the dominant terpene. 
     
     
         13 . A method of producing a cannabis plant, wherein said cannabis plant produces an inflorescence comprising a B D /B D  genotype, a terpene oil content greater than 1.0%, and a terpene profile in which myrcene is not the dominant terpene, said method comprising:
 (i) obtaining a cannabis seed, cutting, or plant cell, from a cannabis plant, or an asexual clone of said cannabis plant of  claim 1 ;   (ii) placing said cannabis seed, cutting, or plant cell in an environment conducive to growth; and   (iii) allowing said cannabis seed, cutting, or plant cell to produce a cannabis plant;   
       wherein the produced cannabis plant produces an inflorescence comprising a B D /B D  genotype, a terpene oil content greater than 1.0%, and a terpene profile in which myrcene is not the dominant terpene. 
     
     
         14 . A cannabis extract from the cannabis plant, or an asexual clone of said cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 . 
     
     
         15 . The cannabis extract of  claim 16 , wherein said extract is selected from the group consisting of kief, hashish, bubble hash, solvent reduced oils, sludges, e-juice, and tinctures. 
     
     
         16 . An edible product comprising cannabis tissue from the cannabis plant, or an asexual clone of said cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 . 
     
     
         17 . An edible product comprising the cannabis extract of  claim 14 . 
     
     
         18 . The cannabis plant, or an asexual clone of said cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 , wherein said plant part is selected from the group consisting of trichomes, sun leaves, or inflorescences. 
     
     
         19 . The Cannabis plant, or an asexual clone of said Cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 , wherein the female inflorescence comprises a cannabidiol (CBD) content that is at least 9.0%, wherein the CBD content comprises the content of acidic and decarboxylated CBD as measured by high performance liquid chromatography (HPLC) and calculated based on dry weight of the inflorescence. 
     
     
         20 . The Cannabis plant, or an asexual clone of said Cannabis plant, or a plant part, tissue, or cell thereof of  claim 1 , wherein the female inflorescence comprises a cannabidiol (CBD) content that is at least 12.0%, wherein the CBD content comprises the content of acidic and decarboxylated CBD as measured by high performance liquid chromatography (HPLC) and calculated based on dry weight of the inflorescence.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.